Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
NKGen Biotech Inc | NKGN | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.34 | 1.22 | 1.35 | 1.25 | 1.35 |
Recent News
Date | Time | Source | Heading |
---|---|---|---|
2/22/2024 | 16:01 | EDGAR2 | Form 8-K - Current report |
2/14/2024 | 20:19 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2/14/2024 | 20:16 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2/14/2024 | 20:14 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2/14/2024 | 20:11 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2/14/2024 | 13:05 | EDGAR2 | Form SC 13G - Statement of acquisition of beneficial.. |
1/22/2024 | 06:12 | EDGAR2 | Form 8-K - Current report |
1/08/2024 | 17:19 | EDGAR2 | Form 8-K - Current report |
12/28/2023 | 16:14 | EDGAR2 | Form 8-K - Current report |
12/27/2023 | 16:02 | EDGAR2 | Form 8-K - Current report |
12/27/2023 | 16:01 | EDGAR2 | Form 8-K - Current report |
12/19/2023 | 13:41 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |
11/14/2023 | 16:39 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
10/24/2023 | 10:56 | DJN | NKGen Biotech Shares Rise 8% After FDA Clears IND.. |
10/24/2023 | 08:05 | EDGAR2 | Form 8-K - Current report |